➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Boehringer Ingelheim
Dow
Mallinckrodt
McKesson

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

B Braun Medical Inc Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for B BRAUN MEDICAL INC, and when can generic versions of B BRAUN MEDICAL INC drugs launch?

B BRAUN MEDICAL INC has five approved drugs.

There are two US patents protecting B BRAUN MEDICAL INC drugs.

There are twenty-five patent family members on B BRAUN MEDICAL INC drugs in twenty-six countries and nine supplementary protection certificates in eight countries.

Summary for B Braun Medical Inc
International Patents:25
US Patents:2
Tradenames:5
Ingredients:5
NDAs:5
Drug Master File Entries: 21

Drugs and US Patents for B Braun Medical Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun Medical Inc MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER meropenem POWDER;INTRAVENOUS 202106-001 Apr 30, 2015 RX No No   Start Trial   Start Trial
B Braun Medical Inc CLOROTEKAL chloroprocaine hydrochloride SOLUTION;INTRATHECAL 208791-001 Sep 26, 2017 RX Yes No 9,504,666   Start Trial Y   Start Trial
B Braun Medical Inc CLOROTEKAL chloroprocaine hydrochloride SOLUTION;INTRATHECAL 208791-001 Sep 26, 2017 RX Yes No   Start Trial   Start Trial
B Braun Medical Inc LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 208474-001 Aug 3, 2018 AP RX No No   Start Trial   Start Trial
B Braun Medical Inc MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER meropenem POWDER;INTRAVENOUS 202106-002 Apr 30, 2015 RX No No   Start Trial   Start Trial
B Braun Medical Inc BUPIVACAINE HYDROCHLORIDE bupivacaine hydrochloride INJECTABLE;SPINAL 209087-001 Apr 2, 2019 AP RX No No   Start Trial   Start Trial
B Braun Medical Inc CLOROTEKAL chloroprocaine hydrochloride SOLUTION;INTRATHECAL 208791-001 Sep 26, 2017 RX Yes No 8,969,412   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for B Braun Medical Inc Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2603514 1990017-4 Sweden   Start Trial PRODUCT NAME: A COMBINATION OF VABORBACTAM AND/OR SALT OR HYDRATE THEREOF, AND MEROPENEM AND/OR A SALT HYDRATE THEREOF, IN PARTICULAR MEROPENEM TRIHYDRATE.; REG. NO/DATE: EU/1/18/1334 20181122
2603514 CA 2019 00015 Denmark   Start Trial PRODUCT NAME: EN KOMBINATION AF VABORBACTAM, OG/ELLER ET SALT OG/ELLER HYDRAT DERAF, OG MEROPENEM, OG/ELLER ET SALT OG/ELLER HYDRAT DERAF, SAERLIGT MEROPENEM TRIHYDRAT; REG. NO/DATE: EU/1/18/1334 20181122
2603514 132019000000051 Italy   Start Trial PRODUCT NAME: COMBINAZIONE DI VABORBACTAM E/O UN SUO SALE E/O UN SUO IDRATO, E MEROPENEM, E/O UN SUO SALE E/O UN SUO IDRATO, IN PARTICOLARE MEROPENEM TRIIDRATO(VABOMERE); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/18/1334, 20181122
2603514 C201930022 Spain   Start Trial PRODUCT NAME: COMBINACION DE VABORBACTAM, Y/O UNA SAL Y/O UN HIDRATO DEL MISMO, Y MEROPENEM, Y/O UNA SAL Y/O UN HIDRATO DEL MISMO, EN PARTICULAR MEROPENM TRIHIDRATO; NATIONAL AUTHORISATION NUMBER: EU/1/18/1334; DATE OF AUTHORISATION: 20181120; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/18/1334; DATE OF FIRST AUTHORISATION IN EEA: 20181120
0126587 96C0023 Belgium   Start Trial PRODUCT NAME: MEROPENEM TRIHYDR; NAT. REGISTRATION NO/DATE: 624 IS 88 F 12 19960205; FIRST REGISTRATION: IT 028949028 19940817
2603514 122019000027 Germany   Start Trial PRODUCT NAME: KOMBINATION VON VABORBACTAM, UND/ODER EIN SALZ UND/ODER EIN HYDRAT DAVON, UND MEROPENEM, UND/ODER EIN SALZ UND/ODER EIN HYDRAT DAVON, INSBESONDERE MEROPENEMTRIHYDRAT; REGISTRATION NO/DATE: EU/1/18/1334 20181120
2603514 300977 Netherlands   Start Trial PRODUCT NAME: EEN COMBINATIE VAN VABORBACTAM, EN/OF EEN ZOUT EN/OF EEN HYDRAAT DAARVAN, EN MEROPENEM, EN/OF EEN ZOUT EN/OF EEN HYDRAAT DAARVAN, IN HET BIJZONDER MEROPENEM TRIHYDRAAT; REGISTRATION NO/DATE: EU/1/18/1334 20181122
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Boehringer Ingelheim
Johnson and Johnson
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.